Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000656855 | SCV000149356 | likely benign | not provided | 2020-09-02 | criteria provided, single submitter | clinical testing | Observed with MLH1 c.-7C>T and in isolation in individuals with MLH1-associated and other cancers (Lee 2005, Fredriksson 2006, Thompson 2014, Hesson 2015, Morak 2018, Lin 2019); Published functional studies are inconclusive: has not undergone independent functional interrogation, but when studied with MLH1 c.-7C>T, not associated with MLH1 promoter methylation and conflicting results regarding impact on MLH1 expression (Hesson 2015, Morak 2018); Case control studies suggest this variant is not associated with gastric cancer in a Chinese population (Zhi 2011); Observed in 0.1665% (471/282862) of alleles in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 30850667, 25762362, 24689082, 11726306, 22136435, 16963262, 15996210, 18726168, 18566915, 26888055, 29472279, 31386297) |
Laboratory for Molecular Medicine, |
RCV000115447 | SCV000539630 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 0.9% (58/6612) Finnish chromosomes |
Department of Pathology and Laboratory Medicine, |
RCV000115447 | SCV000592325 | uncertain significance | not specified | 2015-04-08 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000656855 | SCV000691838 | uncertain significance | not provided | 2022-09-02 | criteria provided, single submitter | clinical testing | BS1 |
Counsyl | RCV000662924 | SCV000785872 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2017-12-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV003492406 | SCV000837989 | likely benign | Hereditary cancer | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000656855 | SCV001153830 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MLH1: BP4, BS1 |
Illumina Laboratory Services, |
RCV000662924 | SCV001308677 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 2 | 2018-08-20 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Color Diagnostics, |
RCV001190167 | SCV001357593 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521973 | SCV001731416 | benign | Hereditary nonpolyposis colorectal neoplasms | 2022-12-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000115447 | SCV002072436 | uncertain significance | not specified | 2019-07-09 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001190167 | SCV002528736 | benign | Hereditary cancer-predisposing syndrome | 2020-10-02 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000115447 | SCV002552410 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000115447 | SCV002773900 | benign | not specified | 2021-09-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149729 | SCV003838265 | likely benign | Breast and/or ovarian cancer | 2022-11-11 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000656855 | SCV002074987 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 09-02-2020 by Lab or GTR ID 506138. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |